New Market Study Published: Sirius Genomics Inc. - Product Pipeline Analysis
Sirius Genomics (Sirius) is a biotechnology company engaged in the development of diagnostic and pharmacogenetic products for the healthcare markets. The company develops genetic test reagents such as DNA based diagnostic (Dx) and pharmacogenetic (PGx) tests for the in vitro markets. Its products are linked up with complementary scientific, medical and business expertise for its effective functioning. The company's specific genotypes (or SNPs) identifies whether a patient will respond to certain sepsis treatments. The company collaborative agreement with Assistance Publique-Hopitaux...
View full press release